
Methylisoindigotin
CAS No. 97207-47-1
Methylisoindigotin( Methylisoindigotin )
Catalog No. M16877 CAS No. 97207-47-1
Meisoindigo(Natura-α; N-Methylisoindigotin; Dian III), a derivative of Indigo naturalis, might induce apoptosis and myeloid differentiation of acute myeloid leukemia (AML).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 58 | In Stock |
![]() ![]() |
10MG | 80 | In Stock |
![]() ![]() |
25MG | 160 | In Stock |
![]() ![]() |
50MG | 245 | In Stock |
![]() ![]() |
100MG | 385 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameMethylisoindigotin
-
NoteResearch use only, not for human use.
-
Brief DescriptionMeisoindigo(Natura-α; N-Methylisoindigotin; Dian III), a derivative of Indigo naturalis, might induce apoptosis and myeloid differentiation of acute myeloid leukemia (AML).
-
DescriptionMeisoindigo(Natura-α; N-Methylisoindigotin; Dian III), a derivative of Indigo naturalis, might induce apoptosis and myeloid differentiation of acute myeloid leukemia (AML).(In Vitro):Meisoindigo (Dian III; 5-20 μM; for 24?hours) inhibits growth of the AML cell lines.Meisoindigo (10?μM; for 24?hours) induces apoptosis of acute myeloid leukemia.Meisoindigo (5-10?μM; for 24?hours) causes cell-cycle arrest.Meisoindigo (5-10?μM; for 24?hours) increases the cleaved caspase-3 and pro-apoptotic Bak, and decreases Bcl-2 and Bcl-xL levels in HL-60 cells.Meisoindigo (10, 30, 50, 100, 150 μM; 24 hours) interdicts LPS-induced (1 μg/mL) NLRP3 inflammasome activation and M1/M2 polarization through down-regulation of TLR4 pathways after OGD/R in HT-22 and BV2 cells.(In Vivo):Meisoindigo (Dian III; 50-150?mg/kg; IP; daily; for 14 days) has anti-leukemic activity in?vivo.Meisoindigo (2, 4, 8, 12 mg/kg; IP; before MCAO and 2 h after reperfusion) significantly reduces infarct volume, ameliorates neurological deficits 3 days after middle cerebral artery occlusion (MCAO) in Wild-type C57BL/6J mice (25-30 g). Meisoindigo reduces edema and lowers AQP4 expression in the brain.
-
In VitroMeisoindigo (Dian III; 5-20 μM; for 24?hours) inhibits growth of the AML cell lines. Meisoindigo (10?μM; for 24?hours) induces apoptosis of acute myeloid leukemia. Meisoindigo (5-10?μM; for 24?hours) causes cell-cycle arrest. Meisoindigo (5-10?μM; for 24?hours) increases the cleaved caspase-3 and pro-apoptotic Bak, and decreases Bcl-2 and Bcl-xL levels in HL-60 cells. Meisoindigo (10, 30, 50, 100, 150 μM; 24 hours) interdicts LPS-induced (1 μg/mL) NLRP3 inflammasome activation and M1/M2 polarization through down-regulation of TLR4 pathways after OGD/R in HT-22 and BV2 cells. Cell Viability Assay Cell Line:HL-60, NB4, U937 leukemic cell lines Concentration:5, 10, 15, 20 μM Incubation Time:For 24?hours Result:Inhibited growth of the AML cell lines in a dose- and time-dependent manner.Apoptosis Analysis Cell Line:HL-60 cells Concentration:10?μM Incubation Time:For 24?hours Result:Induced apoptosis of acute myeloid leukemia.Cell Cycle Analysis Cell Line:HL-60 cells Concentration:5, 10?μM Incubation Time:For 24?hours Result:Caused cell-cycle arrest, with more cells in sub-G1 and G0/G1 phases and fewer cells in the S phase, in a dose-dependent manner.Western Blot Analysis Cell Line:HL-60 cells Concentration:5, 10?μM Incubation Time:For 24?hours Result:Increased the cleaved caspase-3 and pro-apoptotic Bak, and decreased Bcl-2 and Bcl-xL levels in HL-60 cells.
-
In VivoMeisoindigo (Dian III; 50-150?mg/kg; IP; daily; for 14 days) has anti-leukemic activity in?vivo. Meisoindigo (2, 4, 8, 12 mg/kg; IP; before MCAO and 2 h after reperfusion) significantly reduces infarct volume, ameliorates neurological deficits 3 days after middle cerebral artery occlusion (MCAO) in Wild-type C57BL/6J mice (25-30 g). Meisoindigo reduces edema and lowers AQP4 expression in the brain. Animal Model:NOD/SCID mice, 6-8 weeks old, with HL-60 leukemic cellsDosage:50, 100, 150?mg/kg Administration:IP; daily; for 14 days Result:Had anti-leukemic activity in?vivo.
-
SynonymsMethylisoindigotin
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis inducer
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number97207-47-1
-
Formula Weight276.29
-
Molecular FormulaC17H12N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCN(C1=CC=CC=C1/C2=C3C(NC4=C\3C=CC=C4)=O)C2=O
-
Chemical Name(E)-1,1'-dimethyl-[3,3'-biindolinylidene]-2,2'-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lee CC, et al. Leuk Lymphoma. 2010 May;51(5):897-905.
molnova catalog



related products
-
PI3Kδ-IN-16
PI3Kδ-IN-16 is a selective and potent PI3Kδ inhibitor with anticancer and antiproliferative activity, induces cell cycle arrest and apoptosis.
-
W146
W146 is a selective and potent Sphingosine 1-phosphate receptor subtype 1 (S1PR1) antagonist that induces significant but transient hematolymphopenia in mice.
-
Ecdysone
Ecdysone is a major steroid hormone in insects and herbs. Ecdysone triggers mineralocorticoid receptor activation and induces cellular apoptosis. Ecdysone signaling through Ecdysone receptor isoform B1 is required cell autonomously for the muscle death.